Amit Kumar - 31 May 2021 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Chief Executive Officer, Director
Signature
/s/ Amit Kumar
Issuer symbol
ANIX
Transactions as of
31 May 2021
Net transactions value
$0
Form type
4
Filing time
02 Jun 2021, 17:00:15 UTC
Next filing
20 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +2,000,000 $0.000000 2,000,000 01 Jun 2021 Common Stock 2,000,000 $4.02 Direct F1, F2
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 01 Jun 2021 Common Stock 500,000 $4.02 Direct F1, F3
transaction ANIX Restricted Stock Award Disposed to Issuer $0 -1,500,000 -100% $0.000000* 0 31 May 2021 Common Stock 1,500,000 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable as follows: (i) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $5.00, (ii) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $6.00, (iii) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $7.00, and (iv) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $8.00.
F3 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning June 30, 2021.
F4 The vesting requirements were not met and the restricted stock award expired on May 31, 2021.